CSPC Pharmaceutical Group Limited (1093.HK) HKSE

Currency In HKD

AD

Valuation

Market Cap96.3B
Enterprise Value90.85B
P/E Ratio17.66
PEG Ratio-2.18
Price/Sales Ratio2.68
Price/Book Ratio2.08
Enterprise/Revenue2.47
Enterprise/EBITDA10.77

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterDecember 31, 2025

Profitability

Profit Margin0.15
Operating Margin0.15
AD

Management Effectiveness

Return On Assets0.08
Return On Equity0.11

Income Statement

Revenue25.33B
Revenue/Share2.22
Gross Profit16.62B
EBITDA5.24B
Net Income3.78B
Diluted EPS0.33

Balance Sheet

Total Cash8.87B
Total Cash/Share0.77
Total Debt641.38M
Total Debt/Equity0.02
Current Ratio2.19
Book Value Per Share3

Price History

52-Week Change-9.86
52-Week High11.63
52-Week Low6.53
Moving Average 50 Days7.95
Moving Average 200 Days8.72

Statistics

Average Volume94.86M
Shares Outstanding11.41B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.21
Trailing Annual Dividend Yield3.45
Payout Ratio0.64
Last Split Factor8:5
Last Split DateOctober 15, 2020
AD